Making the Move: Bringing Cell and Gene Therapy Development Programs to the United States
White Paper
Aug 27, 2018
Cell and gene therapies (CGTs) represent the next great wave of therapeutic innovation and have led to the development of promising therapies worldwide. While a few of the initial therapies have received marketing approval in the United States (U.S.), there are a number of promising therapies in development outside of the U.S. As these therapies advance through preclinical and clinical development, many companies are considering if, when, and how they should bring their therapies to the U.S. to unlock the commercial potential of the world’s largest biopharmaceutical market.
Contact Us
Contact Us

Email Us

Get in touch today to discover the right solutions for you.

Call Us

We are pleased to speak with you during our standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.